Last reviewed · How we verify
DCB-WH1 ointment — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
DCB-WH1 ointment (DCB-WH1 ointment) — Oneness Biotech Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| DCB-WH1 ointment TARGET | DCB-WH1 ointment | Oneness Biotech Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- DCB-WH1 ointment CI watch — RSS
- DCB-WH1 ointment CI watch — Atom
- DCB-WH1 ointment CI watch — JSON
- DCB-WH1 ointment alone — RSS
Cite this brief
Drug Landscape (2026). DCB-WH1 ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/dcb-wh1-ointment. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab